Literature DB >> 2153102

The insulin-like effects of selenate in rat adipocytes.

O Ezaki1.   

Abstract

Selenate was found to have several insulin-like effects in rat adipocytes: stimulation of glucose transport activity by translocation of two types of glucose transporters from intracellular sites to the plasma membrane, stimulation of cAMP phosphodiesterase activity, and stimulation of ribosomal S6 protein phosphorylation. Furthermore, in intact cells addition of 1 mM selenate stimulated tyrosyl phosphorylation of 210-, 170-, 120-, 95-, 70-, and 60-kDa proteins but failed to stimulate insulin receptor kinase activity, suggesting that selenate stimulated other tyrosine kinase. In the presence of insulin, selenate enhances insulin receptor kinase activity and phosphorylations of insulin-stimulated tyrosyl phosphoproteins. These results may provide clues for the elucidation of the role of selenium in animals and the mechanism of insulin action.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Localization of erythrocyte/HepG2-type glucose transporter (GLUT1) in human placental villi.

Authors:  K Takata; T Kasahara; M Kasahara; O Ezaki; H Hirano
Journal:  Cell Tissue Res       Date:  1992-03       Impact factor: 5.249

Review 2.  Selenium, Vanadium, and Chromium as Micronutrients to Improve Metabolic Syndrome.

Authors:  Sunil K Panchal; Stephen Wanyonyi; Lindsay Brown
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

3.  Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats.

Authors:  D J Becker; B Reul; A T Ozcelikay; J P Buchet; J C Henquin; S M Brichard
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

4.  GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity.

Authors:  Robert Hauffe; Vanessa Stein; Chantal Chudoba; Tanina Flore; Michaela Rath; Katrin Ritter; Mareike Schell; Kristina Wardelmann; Stefanie Deubel; Johannes Florian Kopp; Maria Schwarz; Kai Kappert; Matthias Blüher; Tanja Schwerdtle; Anna P Kipp; André Kleinridders
Journal:  JCI Insight       Date:  2020-06-04

5.  Evidence for altered structure and impaired mitochondrial electron transport function in selenium deficiency.

Authors:  P Rani; K Lalitha
Journal:  Biol Trace Elem Res       Date:  1996-03       Impact factor: 3.738

6.  Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.

Authors:  B-J Ko; S M Kim; K H Park; H S Park; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2014-03-18       Impact factor: 5.095

Review 7.  Hypothalamic redox balance and leptin signaling - Emerging role of selenoproteins.

Authors:  Ting Gong; Daniel J Torres; Marla J Berry; Matthew W Pitts
Journal:  Free Radic Biol Med       Date:  2018-03-05       Impact factor: 7.376

8.  A high-selenium diet induces insulin resistance in gestating rats and their offspring.

Authors:  Min-Shu Zeng; Xi Li; Yan Liu; Hua Zhao; Ji-Chang Zhou; Ke Li; Jia-Qiang Huang; Lv-Hui Sun; Jia-Yong Tang; Xin-Jie Xia; Kang-Ning Wang; Xin Gen Lei
Journal:  Free Radic Biol Med       Date:  2012-02-01       Impact factor: 7.376

9.  Selenium acts as an insulin-like molecule for the down-regulation of diabetic symptoms via endoplasmic reticulum stress and insulin signalling proteins in diabetes-induced non-obese diabetic mice.

Authors:  Daeyoun Hwang; Sujin Seo; Yongkyu Kim; Chuelkyu Kim; Sunbo Shim; Seungwan Jee; Suhae Lee; Mikyong Jang; Minsun Kim; Suyoun Yim; Sang-Koo Lee; Byeongcheol Kang; Insurk Jang; Jungsik Cho
Journal:  J Biosci       Date:  2007-06       Impact factor: 1.826

10.  Promoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes.

Authors:  A G Swick; M Janicot; T Cheneval-Kastelic; J C McLenithan; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.